Figure 1 | Experimental & Molecular Medicine

Figure 1

From: Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy

Figure 1

Effect of AGEs and statin on proliferation of RASMCs. Proliferation was increased with AGEs treatment dose-dependently (A) and decreased with statin dose-dependently (AGE 50 µg/ml) (B). Cell proliferation was determined by MTT assay. Data are expressed as mean ± SEM (n = 5). *P < 0.05 versus control; †P < 0.05 versus AGEs. CTL, control; AGEs, advanced glycation endproducts.

Back to article page